Squarepoint’s Loxo Oncology, Inc LOXO Stock Holding History

Squarepoint’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,810	Closed	-$1.93M	–	2604
2018 Q4	$1.93M	Sell	13,810 -9,759	-41%	-$1.48M	0.02%	686
2018 Q3	$4.03M	Buy	23,569 +19,669	+504%	+$3.31M	0.05%	470
2018 Q2	$677K	Buy	+3,900	New	+$586K	0.01%	1055
2018 Q1	–	Sell	-3,844	Closed	-$324K	–	2418
2017 Q4	$324K	Buy	+3,844	New	+$320K	0.01%	1450
2017 Q3	–	Sell	-6,553	Closed	-$525K	–	2011
2017 Q2	$525K	Buy	+6,553	New	+$363K	0.01%	932

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Squarepoint's LOXO Position: Q1 2019 in Review

Squarepoint sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 13,810 shares — an estimated $1.93M sold.

Squarepoint first reported a position in LOXO in Q2 2017 and held it in 5 quarters. The position peaked at $4.03M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Squarepoint reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Squarepoint sold 13,810 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.93M.
Squarepoint first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 5 quarters.
Squarepoint's Loxo Oncology, Inc position peaked at $4.03M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Squarepoint's 13F filing for Q1 2019, filed 15 May 2019.